Sodium Citrate TSC, chemically trisodium citrate dihydrate (Na₃C₆H₅O₇·2H₂O; CAS 6132-04-3), is a white crystalline or granular material supplied in food, pharmaceutical, and industrial grades. The anhydrous form carries CAS 68-04-2; the dihydrate is the more common commercial species because its crystal water content stabilizes handling and reduces hygroscopicity compared with the anhydrous material. In food additive listings, the substance is designated E331(iii) and is cleared as GRAS under FDA 21 CFR 184.1751. Commercial grade designations include fine powder, granular material in the 30–100 mesh range, and coarse granular material; exact particle size limits are supplier-specific and are confirmed on a certificate of analysis. The theoretical water content of the dihydrate is 12.25% w/w. A 5% w/v aqueous solution at 25 °C exhibits a pH from 7.5 to 9.0, reflecting the fully neutralized sodium citrate species. The product is used where reversible calcium sequestration, sodium contribution, and mild alkaline buffering are required in the same formulation.

Compendial specifications and grade selection

Compendial sodium citrate monographs include USP-NF, Ph. Eur., and FCC. Assay is expressed on the anhydrous basis because the dihydrate contains crystal water and residual moisture. Controlling water content is necessary to prevent sodium content drift when dosage is calculated by weight. Grade selection is driven by microbial and endotoxin limits for parenteral use, lead and arsenic limits for food, and particle size for bulk dry blending. Table 1 summarizes representative acceptance parameters used in commercial certificates of analysis.

Because TSC is hygroscopic above relative humidity 60%, handling and storage require closed containers at 15–25 °C. Batch-to-batch moisture variation within the 11.0–13.0% w/w range changes as-is weight; mass-based dosing should be converted to anhydrous basis when high-precision formulations are specified.

In clinical collection systems, a buffered 0.109 M trisodium citrate solution is used at a whole-blood-to-anticoagulant ratio of 9:1 for coagulation testing. The citrate anion chelates ionized calcium reversibly, preventing thrombin generation until recalcification is performed in the laboratory. Underfilled tubes below 90% of nominal draw volume produce relative citrate excess and can prolong prothrombin time and activated partial thromboplastin time; CLSI H21-A5 establishes handling and rejection criteria for these specimens. A higher 0.129 M citrate solution is used for erythrocyte sedimentation rate at a 4:1 blood-to-anticoagulant ratio. Evaporative water loss from liquid citrate tubes concentrates the chelator and shifts the effective ratio; ISO 6710:2017 sets fill-volume tolerance and closure specifications for evacuated blood collection tubes. Unlike EDTA anticoagulants, citrate does not irreversibly inhibit calcium-dependent testing, but it is unsuitable for samples that require stable cell morphology beyond the immediate testing window.

How does sodium citrate TSC perform as an emulsifying salt in processed cheese?

During processed cheese manufacture, TSC exchanges sodium for calcium at casein phosphate nanoclusters; the citrate anion binds calcium and releases casein for hydration and fat emulsification. Published formulation ranges in processed cheese fall commonly between 1.0% and 3.0% w/w of the final product. TSC is rarely used as the sole emulsifying salt at the upper limit because pH can shift above the target window of 5.6–6.0 and alter melt profile. It is typically preblended with sodium hexametaphosphate or sodium phosphate to balance calcium sequestration and pH buffering. In lay-down cookers operating at 80–85 °C with indirect steam and high-shear agitation, the dry blend is prehydrated in process water before addition. Direct addition of undissolved TSC to the hot cheese mass can create localized calcium-chelation gradients, producing gel pockets and surface oiling during cooling. The hydration requirement is more pronounced with granular TSC than with fine powder because dissolution at the cooker surface is slower. Stoichiometrically, 1.000 g of TSC dihydrate provides 3.40 mmol of citrate; based on a 1:1 calcium–citrate complex, this can chelate approximately 136 mg of calcium. The actual sequestering capacity in a cheese matrix is lower because pH, phosphate competition, and casein-bound calcium reduce the effective ligand activity. Processing records from production-scale lay-down cookers indicate that TSC levels above 3.0% w/w can increase melt length and reduce slice firmness when the calcium-to-citrate molar balance is not compensated by phosphate.

When phosphate-free chelation is required in detergent and descaling operations

When phosphate-free chelation is specified in detergent or descaling operations, TSC is added to bind calcium and magnesium and to inhibit scale formation in hard water. A concentration of 0.5–2.0% w/v is used in single-pass clean-in-place rinses at 60–80 °C; lower temperatures reduce dissolution kinetics and chelation rate. TSC differs from EDTA and NTA because the citrate ligand is readily biodegradable under aerobic wastewater conditions, while its chelating strength for transition metals such as iron and copper is lower than that of EDTA at neutral pH. Alkaline detergent builders combine TSC with sodium carbonate or sodium hydroxide to maintain hardness sequestration at pH 9.5–11.0; above pH 11.0, hydroxide competition can depress calcium binding. Published data for specific clean-in-place configurations is limited; citrate-based builders are recognized alternatives when phosphorus discharge is restricted. The product is not recommended for hypochlorite-containing cleaning regimes because citrate can consume free chlorine and release carbon dioxide.

In beverage concentrates, TSC is introduced as a sodium citrate buffer to regulate perceived acidity and to complex trace metals that would otherwise catalyze oxidation or haze. Use levels are typically below 0.5% w/w in ready-to-drink formulations; solubility in high-sugar concentrates must be verified because high dextrose equivalent syrups reduce water activity and can slow dissolution of granular TSC. It differs from citric acid in that TSC does not significantly depress pH; this permits acid taste correction without requiring a separate neutralization step.

For pharmacopeial alkalinization and buffering, TSC is combined with citric acid in oral solutions to form a citrate buffer that shifts urinary pH and supplies bicarbonate equivalents after hepatic metabolism. Each gram of trisodium citrate dihydrate supplies 3 mEq sodium per millimole or approximately 234 mg sodium per gram; this sodium burden is an operational boundary for sodium-restricted patients. In injection and apheresis settings, TSC is used in anticoagulant citrate dextrose solutions such as ACD-A, which contains 22.0 g/L trisodium citrate dihydrate, 8.0 g/L citric acid monohydrate, and 24.5 g/L dextrose monohydrate. Pharmacopeial monographs for sodium citrate injection require parenteral-grade water, endotoxin control, and particulate matter testing. TSC is incompatible with calcium-containing intravenous solutions unless chelation is intended; simultaneous administration of concentrated calcium salts with citrate anticoagulants can precipitate calcium citrate in line sets when flow rates and mixing are not controlled.

Difference from monosodium citrate, disodium citrate, and potassium citrate

Across the citrate salt series, TSC occupies the fully neutralized sodium end. It carries 3 sodium ions per citrate residue, while monosodium citrate carries 1 and disodium citrate carries 2. This stoichiometry defines the pH difference: monosodium citrate is acidic, disodium citrate is intermediate, and TSC is mildly alkaline in solution. When sodium restriction is required, potassium citrate is selected because it supplies potassium rather than sodium; when sodium contribution is acceptable or required, as in processed cheese and blood collection tubes, TSC is the standard citrate salt. Compared with citric acid, TSC adds alkalinity without a sharp pH drop at equivalent citrate molarity. The dihydrate-to-anhydrous molecular weight ratio is 1.139, so 1.000 g of TSC dihydrate contains 0.878 g of anhydrous trisodium citrate.

In dry blending and storage operations, TSC dihydrate should be kept in closed containers at 15–25 °C and protected from relative humidity above 60%; prolonged exposure to humid air causes caking and surface dissolution. The product is incompatible with strong acids, which decompose citrate and release carbon dioxide, and with strong oxidizers used in chlorinated cleaning regimes. In powder blends containing citric acid, a compatibility study is required because localized moisture can initiate low-level gas evolution and clumping. Processed cheese and beverage lines require dissolution or prehydration at controlled temperature; undissolved granules can create blockages in plate heat exchangers at low line velocities. When switching between TSC dihydrate and anhydrous sodium citrate, the mass correction factor 1.139 must be applied to maintain equivalent citrate and sodium delivery.